IBM Faces Dual Threat: Legal Scrutiny and a 42% Mainframe Collapse
Published on 07/27/2026 at 13:31 | Redaktion boerse-global.de
The numbers are brutal — a 21% monthly decline, a 25% single-day crash that stands as the worst in corporate history, and a stock trading just above its 52-week low at €189.80. Yet beneath the surface of IBM’s July rout lies a more nuanced story than the headlines suggest, one where legal challenges and a deeply cyclical hardware problem intertwine with management’s insistence that the damage is temporary.
The Legal Front Opens
Three US law firms have launched investigations into potential securities law violations, adding a layer of legal uncertainty to an already turbulent period. Bleichmar Fonti & Auld confirmed on July 24 it is examining whether IBM misled investors about the pace of new business closures and the outlook for its Z-mainframe division. The Portnoy Law Firm announced its own probe on July 22, signaling it may pursue a class action on behalf of shareholders, while Hagens Berman is investigating possible violations of US securities regulations.
The trigger for this legal activity was CEO Arvind Krishna’s July 14 preliminary earnings release, in which the company candidly admitted it had “stumbled” and failed to react quickly enough. IBM explicitly stated that numerous large deals had been delayed, accounting for the bulk of the profit shortfall.
The Numbers Behind the Panic
When IBM confirmed its final second-quarter results on July 22, there were no fresh surprises — revenue and adjusted earnings per share matched the preliminary figures released a week earlier. But the damage was already done, concentrated in a single segment that carries outsized importance for the company’s profit profile.
Should investors sell immediately? Or is it worth buying IBM?
Infrastructure revenue fell roughly 7%, with the flagship Z-mainframe business collapsing 42%. This is particularly painful because IBM traditionally monetizes mainframe hardware through attached software — for every dollar of mainframe hardware sold, the company generates roughly three dollars in software revenue. A prolonged mainframe slump would therefore ripple into the higher-margin software division, which itself grew only modestly at 5% to $7.76 billion. Consulting revenue of $5.33 billion was essentially flat.
The software miss is especially concerning because it was supposed to be IBM’s growth engine. While the company’s AI and automation initiatives remain central to management’s narrative, the consulting business is effectively stagnating, creating a slowdown on multiple fronts rather than an isolated hardware problem.
Timing or Structural Shift?
CEO Krishna has been making the rounds in television interviews, arguing that the mainframe weakness is a timing issue rather than a structural decline. He noted that one-third of the large deals deferred in the second quarter have already closed in the third quarter, and attributed the delays to a sharp rise in semiconductor prices that caused enterprise customers to temporarily reallocate budgets from software to physical servers.
CFO Jim Kavanaugh was even more emphatic on the mainframe question, stating: “We see no evidence that customers are migrating away from the mainframe.” The company expects significant strength in the program during the second half of the year.
Independent analysts appear to broadly agree that the selloff was overdone. One enterprise research director described the 25% single-day plunge as excessive, attributing it to an unusually volatile market and uncertainty about how quickly AI investments will generate returns. This distinction — between a genuine structural problem and a market reacting to headline shock — is central to understanding the current opportunity.
Analyst Divergence
The analyst community remains split. Citi cut its price target on July 24 from $255 to $245, while HSBC trimmed its target to roughly $174 with a “Reduce” rating — having already downgraded the stock from “Hold” on July 14, slashing its target from $231 to $191 before another cut to $175.
But not everyone is bearish. Barclays reaffirmed a $288 target on July 21, implying roughly 37% upside from current levels. Wedbush’s Dan Ives maintains a $350 target, more than 64% above the current price. The consensus from 25 analysts surveyed by S&P Global stands at $245.33 with a “Buy” rating, while FactSet’s average of $250.29 carries an “Overweight” recommendation.
IBM at a turning point? This analysis reveals what investors need to know now.
Technical Picture and Risks
The stock’s relative strength index of 35.3 indicates aggressive selling, though it has recovered from the extreme oversold readings in the low-to-mid 20s seen immediately after the crash. Annualized volatility of nearly 85% underscores that this is no longer a quiet blue-chip holding but a highly emotional trade.
The dividend remains intact at $1.69 per share, payable September 10, 2026, extending IBM’s unbroken payout streak dating back to 1916. The company still expects constant-currency revenue growth of 4% to 5% and a roughly $1 billion year-over-year increase in free cash flow.
The consensus analyst target of roughly $231 implies about 23% upside — a gap that reflects genuine skepticism rather than blind faith in a rapid recovery. The current price is pricing in a scenario where mainframe weakness proves structural rather than cyclical. If management’s “delayed, not lost” narrative holds through the second half, the wide distance from the 52-week high and deeply oversold technical conditions argue for a stronger rebound than the market currently anticipates. But the risk is real: another weak quarter in mainframe or software would vindicate the bears and could drive the stock toward new lows rather than analyst targets.
Ad
IBM Stock: New Analysis - 27 July
Fresh IBM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
